{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-198768","form_type":"8-K","ticker":"TCRX","cik":"0001783328","company_name":"TScan Therapeutics, Inc.","filed_at":"2025-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.977909+00:00","generated_at":"2026-05-17T07:20:14.603912+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"low","headline":"TScan Therapeutics updates corporate presentation with adjusted timelines and pipeline updates","bullets":["Company furnished updated corporate presentation on September 9, 2025 for investor meetings.","Presentation includes adjusted timelines for solid tumor program and pipeline updates across hematologic malignancies and solid tumors.","Updates on target discovery initiatives in autoimmunity also included; specific numerical details not disclosed in filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-198768","json":"https://secwatch.observer/filing/0001193125-25-198768.json","markdown":"https://secwatch.observer/filing/0001193125-25-198768.md","text":"https://secwatch.observer/filing/0001193125-25-198768.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/0001193125-25-198768-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1783328/000119312525198768/d125738d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T07:20:14.603912+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}